
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
May 4, 2018 - 00:02:59
Radio and PodcastLive Radio & Podcasts
The FDA has made strides in improving transparency and data access, and has implemented tools to allow the pharmaceutical industry and the public to transform raw data into usable information. One of these tools is calle...
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry is an episode from FDA Drug Information Updates by ReachMD. The FDA has made strides in improving transparency and data access, and has implemented tools to allow the p...
This episode belongs to FDA Drug Information Updates.
Use the player on this page to stream the episode online.
Published Jul 31, 2018, 00:24:45 long, audio available.
The FDA has made strides in improving transparency and data access, and has implemented tools to allow the pharmaceutical industry and the public to transform raw data into usable information. One of these tools is called the FDA Adverse Event Reporting System (FAERS) Public Dashboard. In this episode, the architects of the FAERS Public Dashboard – Deputy Director of the Regulatory Science Staff Suranjan De, and Acting Team Lead in Regulatory Science Information Sanjay Sahoo—both of CDER’s Office of Surveillance and Epidemiology, highlight their work with this new online tool.
You can listen to The FAERS Public Dashboard and its Value to the Pharmaceutical Industry online on Radio and Podcast. Open the player on this page to stream the available audio.
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry is an episode from FDA Drug Information Updates by ReachMD.
This episode is 00:24:45 long.
This episode was published on Jul 31, 2018.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.